Verified peer comparison
Abacus Global Management, Inc. Class A Common Stock vs Apogee Therapeutics Financial Comparison
Abacus Global Management, Inc. Class A Common Stock versus Apogee Therapeutics…
Direct answer
Abacus Global Management, Inc. Class A Common Stock and Apogee Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Verified data
- Abacus Global Management, Inc. Class A Common Stock Revenue
- 235,237,636 USD
- Apogee Therapeutics Revenue
- 0 USD
- Abacus Global Management, Inc. Class A Common Stock Operating income
- 87,053,174 USD
- Apogee Therapeutics Operating income
- -285,595,000 USD